Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Apyx Medical Corporation APYX | Nantahala Capital Management, LLC | 3,493,235 9.990% | 3,493,235 (New Position) | Filing History |
| 2024-10-31 5:44 pm Sale | 2024-10-31 | 13G | Apyx Medical Corporation APYX | Archon Capital Management LLC | 3,115,281 8.990% | -336,749 (-9.76%) | Filing History |
| 2024-10-15 09:18 am Purchase | 2024-09-30 | 13G | Apyx Medical Corporation APYX | ROYCE & ASSOCIATES LP | 2,582,490 7.450% | 423,590 (+19.62%) | Filing History |
| 2024-05-09 07:45 am Unchanged | 2024-05-07 | 13D | Apyx Medical Corporation APYX | Vizirgianakis Stavros G. | 1,746,191 5.040% | 0 (Unchanged) | Filing History |
| 2024-04-05 09:00 am Unchanged | 2024-03-29 | 13D | Apyx Medical Corporation APYX | Archon Capital Management LLC | 3,452,030 9.960% | 0 (Unchanged) | Filing History |
| 2024-04-01 4:15 pm Purchase | 2024-03-25 | 13D | Apyx Medical Corporation APYX | Vizirgianakis Stavros G. | 1,746,191 5.040% | 1,746,191 (New Position) | Filing History |
| 2024-03-25 9:52 pm Sale | 2024-03-22 | 13G | Apyx Medical Corporation APYX | Orin Hirschman | 0 0.000% | -2,040,540 (Position Closed) | Filing History |
| 2024-02-14 5:06 pm Sale | 2023-12-31 | 13G | Apyx Medical Corporation APYX | PURA VIDA INVESTMENTS LLC | 80,000 0.230% | -2,207,560 (-96.50%) | Filing History |
| 2024-02-14 3:05 pm Sale | 2023-12-31 | 13G | Apyx Medical Corporation APYX | Divisadero Street Capital Management, LP | 0 0.000% | -2,056,799 (Position Closed) | Filing History |
| 2024-02-14 07:32 am Sale | 2023-12-31 | 13G | Apyx Medical Corporation APYX | RTW Investments, LP | 1,025,963 3.000% | -2,372,316 (-69.81%) | Filing History |
| 2024-02-13 10:58 am Unchanged | 2023-12-31 | 13G | Apyx Medical Corporation APYX | Archon Capital Management LLC | 3,452,030 9.960% | 0 (Unchanged) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Apyx Medical Corporation APYX | Orin Hirschman | 2,040,540 5.900% | 156,259 (+8.29%) | Filing History |
| 2024-02-02 11:56 am Sale | 2023-12-29 | 13G | Apyx Medical Corporation APYX | Cowen Financial Products LLC | 0 0.000% | -1,775,793 (Position Closed) | Filing History |
| 2024-01-23 09:52 am Unchanged | 2023-12-31 | 13G | Apyx Medical Corporation APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 0 (Unchanged) | Filing History |
| 2024-01-23 09:49 am Purchase | 2023-12-31 | 13G | Apyx Medical Corporation APYX | ROYCE & ASSOCIATES LP | 2,158,900 6.230% | 2,158,900 (New Position) | Filing History |
| 2023-08-14 08:00 am Purchase | 2023-08-11 | 13G | Apyx Medical Corporation APYX | Orin Hirschman | 1,884,281 5.400% | 197,805 (+11.73%) | Filing History |
| 2023-06-12 8:59 pm Sale | 2023-06-06 | 13G | Apyx Medical Corporation APYX | Orin Hirschman | 1,686,476 4.900% | -309,524 (-15.51%) | Filing History |
| 2023-05-19 5:17 pm Purchase | 2023-05-18 | 13G | Apyx Medical Corporation APYX | Divisadero Street Capital Management, LP | 2,056,799 5.900% | 2,056,799 (New Position) | Filing History |
| 2023-05-12 06:42 am Purchase | 2023-05-11 | 13G | Apyx Medical Corporation APYX | Orin Hirschman | 1,996,000 5.800% | 1,996,000 (New Position) | Filing History |
| 2023-02-14 2:45 pm Sale | 2022-12-31 | 13G | Apyx Medical Corporation APYX | PURA VIDA INVESTMENTS LLC | 2,287,560 6.610% | -207,877 (-8.33%) | Filing History |